February 10, 2021 • 12:00 PM - 2:00 PM ET
Employers have long realized the various impacts that chronic diseases can have on individuals within their workforce – both from an HR perspective and a medical-cost perspective. And while the pandemic has both exacerbated and underscored the importance of chronic condition management, many HR and benefits teams were forced to hit the pause button or say ‘not yet’ with some of the innovations and launches that may have been planned and re-prioritize where focus needs to lie. In this webinar series, we discuss the chronic conditions that most impact employers from a cost and productivity perspective, examine current thinking in regards to benefit offerings in this new Covid-world, and share insights and recommendations to best address the impact of chronic conditions on the workforce.
Webinar Agenda:
Employer Perspectives: Strategies and Approaches to Disease Prevention, Monitoring, and Management in 2021
This panel of HR and Benefits executives shares their insights and experience in helping their employees affected by chronic conditions achieve better health outcomes – knowing healthy employees are more productive employees – while lowering health care costs for their organization through the prevention and management of chronic diseases. Knowing that the pandemic has both exacerbated and underscored the importance of chronic condition management, hear about different considerations, approaches, and strategies being evaluated in 2021.
- Understand the risks those with chronic diseases face during the pandemic and steps employers can take now to help
- Discuss various discovery methods for employees to better understand their status with disease and what their own data could tell them to become better stewards of their own health
- Identify the types of programs that have traditionally led to the most impactful results – from cost-savings to employee well-being and satisfaction – and what may be the same or different during, and after, the pandemic
- Examine best practices to implementing disease prevention, monitoring, and management programs as a part of your benefit offerings
- Learn strategies to overcome common engagement struggles, such as providing incentives to drive behavior change and/or disincentives for inaction
Moderator:
![]() |
Neil Goldfarb President and CEO Greater Philadelphia Business Coalition on Health View Bio |
Panelists:
![]() |
Benjamin Hagan Director, Benefits AT&T View Bio |
![]() |
David Hines Executive Director, Employee Benefits Metro Nashville Public Schools View Bio |
![]() |
Kirsten John Vice President, Health Benefit Manager TD Bank View Bio |
![]() |
Gina Ross Murdoch President and CEO Multiple Sclerosis Association of America (MSAA) View Bio |
Evaluate the Impact of Osteoarthritis on Employers
Osteoarthritis (OA), the most common form of arthritis, affects more than 32.5 million US adults, according to the CDC. OA can cause pain, stiffness, and swelling, and usually develops slowly, but gets worse over time, the CDC continues, yet there is no cure. Since OA is more prevalent in the working age population, and a significant portion of individuals with OA have a moderate to severe condition, OA impacts workers’ productivity, as well as an organization’s direct health care costs, and disability. This panel examines why employers and other plan sponsors should be aware of the impact of osteoarthritis (OA) on their workforce, and considerations those charged with managing employee benefits should take into account.
- Gain a better understanding of disease, such as what OA is, what causes OA, and the risk factors that may lead to OA
- Examine the effects OA can have on workers – From productivity, to absenteeism, and more
- Discuss the current options available for managing the pain of OA – Nonpharmacologic, pharmacotherapy, and surgery
- Consider the effectiveness, appropriateness, and/or tolerability of current options and where unmet needs may still exist
- Identify the key considerations HR and benefits teams should take into account when evaluating the impact of OE on their business and workforce
![]() |
Brian Gifford, PhD Director, Research and Analytics Integrated Benefits Institute View Bio |
![]() |
Heather Sell, PharmD, BCPS Director, National Employer Medical Outcomes Specialist Pfizer View Bio |
![]() |
Tom Sondergeld Vice President, Enterprise Growth Strategy Carrot View Bio |
Speaking and sponsorship opportunities still available. Please contact Gina.Glendening@worldcongress.com for details.